Gene · 1870
Papers2,847
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,847
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Analysis of adverse drug reactions/events of cancer chemotherapy and the potential mechanism of Danggui Buxue decoction against bone marrow suppression induced by chemotherapy. | Front Pharmacol | 2023 | 37654610 | PubTator, text mining | PubMed |
| Childhood-onset systemic lupus erythematosus: characteristics and the prospect of glucocorticoid pulse therapy. | Front Immunol | 2023 | 37638017 | PubTator, text mining | PubMed |
| Chromosomal instability and a deregulated cell cycle are intrinsic features of high-risk gastrointestinal stromal tumours with a metastatic potential. | Mol Oncol | 2023 | 37622176 | PubTator, text mining | PubMed |
| p53-dependent R-loop formation and HPV pathogenesis. | Proc Natl Acad Sci U S A | 2023 | 37611058 | PubTator, text mining | PubMed |
| Genetics of enzymatic dysfunctions in metabolic disorders and cancer. | Front Oncol | 2023 | 37601653 | PubTator, text mining | PubMed |
| Breast cancer patient-derived microtumors resemble tumor heterogeneity and enable protein-based stratification and functional validation of individualized drug treatment. | J Exp Clin Cancer Res | 2023 | 37596623 | PubTator, text mining | PubMed |
| Predicting the impact of sequence motifs on gene regulation using single-cell data. | Genome Biol | 2023 | 37582793 | PubTator, text mining | PubMed |
| Cancer stem cells in brain tumors: From origin to clinical implications. | MedComm (2020) | 2023 | 37576862 | PubTator, text mining | PubMed |
| Dysbindin Domain-Containing 1 in Prostate Cancer: New Insights into Bioinformatic Validation of Molecular and Immunological Features. | Int J Mol Sci | 2023 | 37569304 | PubTator, text mining | PubMed |
| MAGI1 Prevents Senescence and Promotes the DNA Damage Response in ER+ Breast Cancer. | Cells | 2023 | 37566008 | PubTator, text mining | PubMed |
| Lnc-ZEB2-19 Inhibits the Progression and Lenvatinib Resistance of Hepatocellular Carcinoma by Attenuating the NF-κB Signaling Pathway through the TRA2A/RSPH14 Axis. | Int J Biol Sci | 2023 | 37564197 | PubTator, text mining | PubMed |
| Systematic analysis of the prognosis and immune infiltration of E2Fs in thyroid carcinoma. | Front Genet | 2023 | 37560385 | PubTator, text mining | PubMed |
| Temporal transcriptome features identify early skeletal commitment during human epiphysis development at single-cell resolution. | iScience | 2023 | 37554462 | PubTator, text mining | PubMed |
| PFDN2 promotes cell cycle progression via the hnRNPD-MYBL2 axis in gastric cancer. | Front Oncol | 2023 | 37538116 | PubTator, text mining | PubMed |
| Fragment-based design, synthesis and biological evaluation of theophylline derivatives as ATAD2 inhibitors in BT-549 cells. | J Enzyme Inhib Med Chem | 2023 | 37533352 | PubTator, text mining | PubMed |
| Cuproptosis-related lncRNAs potentially predict prognosis and therapy sensitivity of breast cancer. | Front Pharmacol | 2023 | 37529698 | PubTator, text mining | PubMed |
| Molecular classification of urothelial bladder carcinoma. | Mol Biol Rep | 2023 | 37525073 | PubTator, text mining | PubMed |
| MicroRNA targeting: A novel therapeutic intervention for ovarian cancer. | Biochem Biophys Rep | 2023 | 37521375 | PubTator, text mining | PubMed |
| Aberrant AHRR, ADAMTS2 and FAM184 DNA Methylation: Candidate Biomarkers in the Oral Rinse of Heavy Smokers. | Biomedicines | 2023 | 37509437 | PubTator, text mining | PubMed |
| Whole Transcriptome Analysis of Intervention Effect of Sophora subprostrate Polysaccharide on Inflammation in PCV2 Infected Murine Splenic Lymphocytes. | Curr Issues Mol Biol | 2023 | 37504299 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1870/papers?page=11